Table 1.
Antigen | Age group (years) | Site | No of participants | Median age (IQR) | Median OD (IQR) | p value | ||
---|---|---|---|---|---|---|---|---|
Walukuba vs Kihihi | Walukuba vs Nagongera | Kihihi vs Nagongera | ||||||
MSP1-19 | 1–4 | Walukuba | 12 | 3 (2–4) | 0.71 (0.60–1.10) | 0.08 | 0.041 | 0.44 |
Kihihi | 18 | 3 (1–4) | 0.90 (0.70–1.17) | |||||
Nagongera | 24 | 1 (1–3) | 1.00 (0.73–1.29) | |||||
5–15 | Walukuba | 16 | 12 (6–13) | 0.80 (0.65–1.25) | 0.5 | 0.4 | 0.8 | |
Kihihi | 76 | 12 (8–13) | 0.89 (0.63–1.12) | |||||
Nagongera | 74 | 11 (7–13) | 0.87 (0.63–1.17) | |||||
>15 | Walukuba | 64 | 28 (20–40) | 0.82 (0.61–1.1) | 0.029 | 0.011 | 0.4 | |
Kihihi | 181 | 35 (25–48) | 0.97 (0.70–1.27) | |||||
Nagongera | 116 | 39 (25–55) | 1.00 (0.67–1.30) | |||||
Total | 581 | |||||||
AMA-1 | 1–4 | Walukuba | 18 | 2 (1–3) | 0.86 (0.59–1.10) | 0.95 | 0.18 | 0.19 |
Kihihi | 21 | 3 (2–4) | 0.79 (0.65–1.11) | |||||
Nagongera | 63 | 3 (2–4) | 0.92 (0.67–1.2) | |||||
5–15 | Walukuba | 76 | 9 (6–12) | 0.92 (0.67–1.07) | 0.005 | 0.0001 | 0.6 | |
Kihihi | 125 | 11 (8–13) | 1.1 (0.80–1.15) | |||||
Nagongera | 251 | 9 (7–12) | 1.1 (0.85–1.2) | |||||
>15 | Walukuba | 89 | 27 (22–32) | 0.72 (0.61–0.88) | 0.0001 | 0.0007 | 0.62 | |
Kihihi | 197 | 34 (22–47) | 0.85 (0.68–1.1) | |||||
Nagongera | 189 | 34 (22–50) | 0.87 (0.65–1.1) | |||||
Total | 1029 |
Statistically significant values (p < 0.05) are in italics